Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1.
Researchers
Lyudmila Bazhenova, Nofisat Ismaila, Greg Durm, Janet Freeman-Daily, Hidehito Horinouchi, Gary R MacVicar, Deebya Raj Mishra, Bruna Pellini, Erin L Schenk, Navneet Singh, Natasha B Leighl
Abstract
<i>Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the</i> <i>ASCO Guidelines Methodology Manual</i><i>. ASCO Living Guidelines follow the</i> <i>ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines</i><i>. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only). Updates are published regularly and can be found at</i> <i>https://ascopubs.org/nsclc-non-da-living-guideline</i>.Source: PubMed (PMID: 42190141)View Original on PubMed